+28.2%
MRNA vs UPST
-16.7%
+44.9%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | UPST | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -4.0% | +0.7% | -2.5% |
| 7D | -10.1% | -8.1% | -2.0% | -8.4% |
| 30D | +126.7% | -14.3% | +141.0% | +136.1% |
| 3M | +184.1% | -16.6% | +200.8% | +197.3% |
| 6M | +143.3% | -7.3% | +150.6% | +148.6% |
| YTD | +359.9% | -40.8% | +400.6% | +401.0% |
| 1Y | +454.2% | -62.4% | +516.6% | +539.8% |
| All | +28.2% | -16.7% | +44.9% | +18.6% |
Cumulative growth
Daily Returns
Daily percentage return beside UPST.
Daily Out/Under-Performance
Portfolio return minus UPST return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × UPST return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded UPST wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling